The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there is a randomized clinical trial I'm going now I'm rolling about 1500 women who are high risk because of a prior history of preeclampsia and they're starting the Statin pravastatin versus placebo earlier around 12 weeks of gestation so right after the first trimester the primary outcome is going to be a proportion that developed preeclampsia or patina loss and maternal death and they're looking at other things like preterm delivery
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there was one study that was published where they gave women for pregnant who are increased risk of preeclampsia pravastatin starting at 35 weeks gestation and didn't show any benefit in preventing preeclampsia but this isn't really surprising because it was just given way too late